Recommended Issuance of Bonus Shares, subject to shareholders approval and any other applicable regulatory and statutory approval, in ratio of 1:4 i.e. 1(one) new fully paid up Equity Shares ....

Titan Biotech Ltd has announced the outcome of its Board Meeting held on September 3, 2026, where it considered and approved the issuance of bonus shares to equity shareholders in the ratio of 1:4, increase in authorized share capital, and re-appointment of an independent director. The company has also scheduled its 34th Annual General Meeting for September 29, 2026, and fixed the record date for the purpose of determining members eligible to vote on the resolutions set out in the Notice of the AGM.